Division of Experimental Medicine, McGill University, Montreal, QC, Canada.
Center for Advanced Research in Sleep Medicine, Research Centre, Hôpital du Sacré-Coeur de Montréal (CIUSSS du Nord de-L'Île-de-Montréal), Montreal, QC, Canada.
Sci Rep. 2022 Jan 31;12(1):1657. doi: 10.1038/s41598-022-05598-w.
Temporomandibular disorders (TMD) patients can present clinically significant jaw pain fluctuations which can be debilitating and lead to poor global health. The Graded Chronic Pain Scale evaluates pain-related disability and its dichotomous grading (high/low impact pain) can determine patient care pathways and in general high-impact pain patients have worse treatment outcomes. Individuals with low-impact TMD pain are thought to have better psychosocial functioning, more favorable disease course, and better ability to control pain, while individuals with high-impact pain can present with higher levels of physical and psychological symptoms. Thereby, there is reason to believe that individuals with low- and high-impact TMD pain could experience different pain trajectories over time. Our primary objective was to determine if short-term jaw pain fluctuations serve as a clinical marker for the impact status of TMD pain. To this end, we estimated the association between high/low impact pain status and jaw pain fluctuations over three visits (≤ 21-day-period) in 30 TMD cases. Secondarily, we measured the association between jaw pain intensity and pressure pain thresholds (PPT) over the face and hand, the latter measurements compared to matched pain-free controls (n = 17). Jaw pain fluctuations were more frequent among high-impact pain cases (n = 15) than low-impact pain cases (n = 15) (OR 5.5; 95% CI 1.2, 26.4; p value = 0.033). Jaw pain ratings were not associated with PPT ratings (p value > 0.220), suggesting different mechanisms for clinical versus experimental pain. Results from this proof-of-concept study suggest that targeted treatments to reduce short-term pain fluctuations in high-impact TMD pain is a potential strategy to achieve improved patient perception of clinical pain management outcomes.
颞下颌关节紊乱(TMD)患者可能会出现临床上显著的颌骨疼痛波动,这可能会使人虚弱,并导致整体健康状况不佳。分级慢性疼痛量表评估与疼痛相关的残疾,其二分定级(高/低影响疼痛)可确定患者的护理途径,一般来说,高影响疼痛患者的治疗效果更差。低影响 TMD 疼痛患者被认为具有更好的社会心理功能、更有利的疾病过程和更好的控制疼痛的能力,而高影响疼痛患者可能表现出更高水平的身体和心理症状。因此,有理由相信低影响和高影响 TMD 疼痛患者可能会随着时间的推移经历不同的疼痛轨迹。我们的主要目的是确定短期颌骨疼痛波动是否是 TMD 疼痛影响状态的临床标志物。为此,我们在 30 例 TMD 病例中估计了高/低影响疼痛状态与三次就诊(≤21 天)期间颌骨疼痛波动之间的关联。其次,我们测量了颌骨疼痛强度与面部和手部压力疼痛阈值(PPT)之间的关联,后者的测量与匹配的无痛对照组(n=17)进行比较。高影响疼痛病例(n=15)比低影响疼痛病例(n=15)中更频繁出现颌骨疼痛波动(OR 5.5;95%CI 1.2, 26.4;p 值=0.033)。颌骨疼痛评分与 PPT 评分无关(p 值>0.220),这表明临床疼痛与实验疼痛的机制不同。这项概念验证研究的结果表明,针对高影响 TMD 疼痛减少短期疼痛波动的靶向治疗可能是改善患者对临床疼痛管理结果的感知的一种策略。